Log out

Collplant Biotechnologies Ltd (CLGN)

$9.35 0.11 (1.16%)

16:00 EDT CLGN Stock Quote Delayed 30 Minutes

Volume:

Previous Close $9.35

Market Cap 32.01M

PE Ratio -

EPS -

Volume (Avg. Vol.) 8,600

Day's Range 9.11 - 9.58

52-Week Range 3.35 - 14.55

Dividend & Yield N/A (N/A)

CLGN Stock Predictions, Articles, and Collplant Biotechnologies Ltd News

From InvestorPlace
From the Web

7 Healthcare Stocks Worth Your Time Now

By Louis Navellier, Editor, Growth Investor Mar 9, 2020

These healthcare stocks have great financials now, and in the future. They all represent the future of medicine, and offer big growth.

The Dow Rose 373 Points. Are Earnings Too Good to Be True?

From Barron's Aug 5, 2020

The stock market continues to rise as earnings season continues apace. Some strategists are starting to worry that the recovery in earnings growth is unassignable.

The Dow Is Up 300 Points. Here’s Why the Stock Market Is Looking Past Dismal Jobs Data.

From Barron's Aug 5, 2020

The ADP jobs report was terrible. The ISM Services survey was not. What to make of the mixed messages?

Novavax Stock Soars, Beyond Meat Drops as the Dow Marches Ahead

From Barron's Aug 5, 2020

U.S. markets were in a sea of green as investors digested a fresh wave of earnings data while also keeping an eye on negotiations in Washington over the next coronavirus relief package.

A Stimulus Plan Seems Very Far Away. Why the Stock Market Rose Anyway.

From Barron's Aug 4, 2020

“So maybe, just maybe, Mr. Market is looking at the ‘fiscal cliff’ as an unnecessary cause for worry,” one strategist writes.

Stocks Swing Back to Notch Small Gains

From Barron's Aug 4, 2020

Upbeat economic news contributed to the reversal.

Take-Two Stock Jumps, Microsoft Slips, and the Stock Market Is Yawn Inducing

From Barron's Aug 4, 2020

It’s a quiet August trading day, as investors digest earnings and wait for an aid package.

Navellier Ratings

Total Grade

Buy

Collplant Biotechnologies Ltd (CLGN)

CLGN Stock Predictions, Articles, and Collplant Biotechnologies Ltd News

7 Healthcare Stocks Worth Your Time Now

The Dow Rose 373 Points. Are Earnings Too Good to Be True?

The Dow Is Up 300 Points. Here’s Why the Stock Market Is Looking Past Dismal Jobs Data.

Novavax Stock Soars, Beyond Meat Drops as the Dow Marches Ahead

A Stimulus Plan Seems Very Far Away. Why the Stock Market Rose Anyway.

Stocks Swing Back to Notch Small Gains

Take-Two Stock Jumps, Microsoft Slips, and the Stock Market Is Yawn Inducing

Navellier Ratings

Total Grade

Subscriber Sign in